Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Hair loss is a common side effect of hormone treatments for cancer.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Some cancer treatments cause different types of hair loss, but scalp cooling can help prevent it.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Light diffraction helps in eye surgery, brain treatments, and detecting hair loss and genetic diseases.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

The treatment process effectively removes many pollutants from cosmetics wastewater, but more research is needed to improve it.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

The document lists dermatology topics across life stages and notes hair loss can affect self-esteem and early skin cancer treatment is crucial.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

No increased skin cancer risk was found in alopecia patients treated with photobiomodulation.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Different scalp conditions can lead to hair loss or tumors, with treatments varying from creams to surgery; early detection is crucial.

Childhood cancer diagnosis leads to long-term physical and emotional health issues in parents.

Nanoparticles improve skin treatment but need more research on safety and effectiveness.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Chemotherapy targets all dividing cells, causing side effects like nausea and hair loss.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.